leisure time -WSS

leisure time

author：comprehensive 2025-09-27 14:10:30 - browse：211

Are biotech’s dog days over? What’s a PIPE? And what can unseat Wegovy?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We dive into the the latest craze in the world of biotech finance, involving hedge funds and some insider information, and explain why not everyone thinks it’s such a good idea. We also discuss a banner month for biotech stocks and the latest twist in obesity research.

For more on what we cover, here’s more on PIPEs; here’s the news from Viking Therapeutics; here’s the latest in MASH; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Saudi VC loops Novo Nordisk, biotech VCs into longevity incubator

explore

WSS

Takeda, Janssen join wearable maker to measure scratching

CDC recommends RSV monoclonal antibody for infants

Organ aging and disease risk measured by new blood test

30 years of 'Listening to Prozac'

Fetal surgery at risk from Dobbs and new abortion restrictions

CDC director unscathed in first congressional testimony

knowledge

leisure time

leisure time

The cancer drug shortage isn’t new — and neither are the solutions

Mayo Clinic plans $5B tech

Medical records are filled with copy

FAA sets up new process for Hawaii air tour operators to fly at lower altitudes after fatal crashes

Medicare details structure of new drug price negotiation program

A controversial new treatment promises to make little people taller

How to save PrEP access — and even expand it

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

After affirmative action ruling, medical educators look to 'holistic review'

The cancer stories no one wants to hear

hotspot

30 years of 'Listening to Prozac'

The a glaring gap in research on serious mental illness and primary care

Takeda, Janssen join wearable maker to measure scratching

How to pay for weight loss drugs and save Medicare

UnitedHealth has 90,000 doctors — 10% of all physicians in U.S.

2 officers injured in shooting in Orlando, police say

leisure time

knowledge

explore

focus